ATE189122T1 - Monoklonale anti-idiotypische anti - ca125 antikörper und sie enthaltende pharmazeutische zusammensetzung - Google Patents

Monoklonale anti-idiotypische anti - ca125 antikörper und sie enthaltende pharmazeutische zusammensetzung

Info

Publication number
ATE189122T1
ATE189122T1 AT94918798T AT94918798T ATE189122T1 AT E189122 T1 ATE189122 T1 AT E189122T1 AT 94918798 T AT94918798 T AT 94918798T AT 94918798 T AT94918798 T AT 94918798T AT E189122 T1 ATE189122 T1 AT E189122T1
Authority
AT
Austria
Prior art keywords
antibodies
idiotypic
pct
pharmaceutical compositions
compositions containing
Prior art date
Application number
AT94918798T
Other languages
English (en)
Inventor
Uwe Dr Med Wagner
Harald Schlebusch
Original Assignee
Uwe Dr Med Wagner
Harald Schlebusch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uwe Dr Med Wagner, Harald Schlebusch filed Critical Uwe Dr Med Wagner
Application granted granted Critical
Publication of ATE189122T1 publication Critical patent/ATE189122T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C07K16/4258—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
    • C07K16/4266—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig against anti-tumor receptor Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57545—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the ovaries
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/686—Anti-idiotype
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT94918798T 1993-05-27 1994-05-26 Monoklonale anti-idiotypische anti - ca125 antikörper und sie enthaltende pharmazeutische zusammensetzung ATE189122T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93108583 1993-05-27
PCT/EP1994/001719 WO1994027637A1 (en) 1993-05-27 1994-05-26 Monoclonal anti-idiotypic anti-ca125 antibodies and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
ATE189122T1 true ATE189122T1 (de) 2000-02-15

Family

ID=8212947

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94918798T ATE189122T1 (de) 1993-05-27 1994-05-26 Monoklonale anti-idiotypische anti - ca125 antikörper und sie enthaltende pharmazeutische zusammensetzung

Country Status (9)

Country Link
US (1) US5858361A (de)
EP (1) EP0700305B1 (de)
JP (1) JP3764165B2 (de)
AT (1) ATE189122T1 (de)
AU (1) AU6997394A (de)
CA (1) CA2163868C (de)
DE (1) DE69422809T2 (de)
ES (1) ES2144522T3 (de)
WO (1) WO1994027637A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0837696B1 (de) * 1995-06-07 2010-02-24 Immunomedics, Inc. Verbesserte abgabe von diagnostischen und therapeutischen stoffen an einem zielort
US8038994B2 (en) 1996-05-15 2011-10-18 Quest Pharmatech Inc. Combination therapy for treating disease
WO1997042973A1 (en) * 1996-05-15 1997-11-20 Altarex, Corp. Method and composition for reconforming multi-epitopic antigens to initiate an immune response
GB2413960A (en) * 2001-03-21 2005-11-16 Altarex Inc Treating ovarian cancer
AU2002335932B2 (en) * 2001-03-21 2007-11-01 Altarex Medical Corp. Therapeutic compositions that alter the immune response
ES2304264A1 (es) * 2001-10-26 2008-10-01 Altarex Medical Corp. Terapia de combinacion para tratar enfermedades.
DE10210239A1 (de) * 2002-03-08 2003-09-25 Cellcontrol Biomedical Lab Ag Spezifische Ab1'-Antikörper gegen das Tumor-assoziierte Antigen CA125
MXPA05003884A (es) 2002-10-16 2005-10-05 Euro Celtique Sa Anticuerpos que enlazan polipeptidos ca 125/0772p a celulas asociadas y metodos de uso de los mismos.
WO2006099175A2 (en) * 2005-03-11 2006-09-21 Euro-Celtique S.A. Compositions comprising an anti-ca125 antibody and a cytotoxic compound and their use for the treatment of cancer
ITFI20060163A1 (it) * 2006-06-29 2006-09-28 Menarini Internat Operations Luxembourg Sa Composizione farmaceutica contenente un anticorpo monoclonale anti idiotipico anti-ca-125 ed alluminio
WO2009032128A1 (en) * 2007-08-28 2009-03-12 Abbott Biotechnology Ltd. Compositions and methods comprising binding proteins for adalimumab

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01224399A (ja) * 1988-03-02 1989-09-07 Sumitomo Electric Ind Ltd 抗イディオタイプ抗体
ATE130764T1 (de) * 1988-10-17 1995-12-15 Cancer Res Campaign Tech Anti-idiotyp antikörper induktion eines antitumorenresponses.

Also Published As

Publication number Publication date
CA2163868A1 (en) 1994-12-08
US5858361A (en) 1999-01-12
CA2163868C (en) 2008-01-08
EP0700305A1 (de) 1996-03-13
ES2144522T3 (es) 2000-06-16
DE69422809D1 (de) 2000-03-02
DE69422809T2 (de) 2000-10-12
WO1994027637A1 (en) 1994-12-08
JPH08510460A (ja) 1996-11-05
EP0700305B1 (de) 2000-01-26
JP3764165B2 (ja) 2006-04-05
AU6997394A (en) 1994-12-20

Similar Documents

Publication Publication Date Title
DE69226431D1 (de) Zellrezeptor spezifische monoklonale antikörper gegen stammzell-faktor-rezeptor
GR3035388T3 (en) MONOCLONAL ANTIBODY ACTIVE AGAINST CD44v6
ATE171472T1 (de) Klonierung und expression von humanisierten monoklonalen antikörpern gegen menschliches interleukin-4
ATE208820T1 (de) Humanisierte antikoerper
ATE189122T1 (de) Monoklonale anti-idiotypische anti - ca125 antikörper und sie enthaltende pharmazeutische zusammensetzung
MX9704897A (es) Secuencias del anticuerpo anti-idiotipo monoclonal recombinante 3h1 relacionadas con el antigeno carcinoembrionico humano.
EP0552296A4 (en) Mouse monoclonal antibodies
GR3029483T3 (en) Antibodies against t-cells as therapeutics
EP1491632A3 (de) Anti-alphavbeta3 humanizierte monoklonale Antikörper
DE3580382D1 (de) Monoklonale antikoerper gegen alpha-2 interferon und hybridomas, die solche antikoerper produzieren.
DK0865271T3 (da) Stabiliserede solbeskyttelsespræparater
NZ337601A (en) Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics by inhibiting IgE expression
BG104373A (en) Polymorphous forms of dofetilide
ATE279521T1 (de) Regulierende nukleinsaeuresequenzen und verwendungen
ATE328088T1 (de) Transketolase-verwandtes protein
MX9701948A (es) Epimeros de (22rs-n-(1,1,1-trifluoro-2-fenilprop-2-il)-3-oxo-4-aza-5alfa-androst-1-e n-17beta-carboxamida.
DE69836096D1 (de) Anti-idiotypische monoklonale antikörper, deren verwendung zur aktiven immuntherapie bösartiger tumoren, und zusammensetzungen die diese enthalten
AU6162794A (en) Carcinoma associated antigen (ng1) monoclonal antibodies against ng1, methods of producing these antibodies and use therefor
WO2007022251A3 (en) Prostatic acid phosphatase and prostate cancer
AU2003204088A1 (en) Anti-idiotypic monoclonal antibodies, their use in the active immunotherapy of malignant tumors, and compositions containing them
AU2003204129A1 (en) Anti-idiotype monoclonal antibodies, their use in active immunotherapy of malignant tumors and compositions containing them
HUP0003029A2 (hu) Ankrod specifikus monoklonális antitestek, antitestfragmentumok, keverékeik és alkalmazásuk
IL133224A0 (en) Ancrod specific monoclonal antibodies antibody fragments mixtures or derivatives thereof and use of the same

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification